Perturbations of Adjuvant Chemotherapy on Cardiovascular Responses and Exercise Tolerance in Patients with Early-Stage Breast Cancer
Journal
Biology
Journal Volume
10
Journal Issue
9
Date Issued
2021-09-13
Author(s)
Abstract
Adjuvant chemotherapies are commonly used for treating early-stage breast cancer. However, whether chemotherapeutic regimens affect exercise tolerance and cardiovascular responses remains unclear. Therefore, we investigated the effects of receiving CAF and AC-T on exercise tolerance and cardiovascular responses in patients with early-stage breast cancer.
Subjects
AC-T; CAF; SEVR; cardiovascular responses; doxorubicin; taxanes
SDGs
Publisher
MDPI
Type
journal article